These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1379839)

  • 21. Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506.
    Radermacher J; Meiners M; Bramlage C; Kliem V; Behrend M; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
    Transpl Int; 1998; 11(1):3-10. PubMed ID: 9503547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of serum triglyceride concentration on the fluctuation of whole blood concentration of cyclosporin A in patients.
    Nakamura T; Kakumoto M; Sakaeda T; Nagahiro K; Ohmichi R; Yamashita K; Nishiguchi K; Hirai M; Okumura K
    Biol Pharm Bull; 2001 Jun; 24(6):683-7. PubMed ID: 11411559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous injection of oral cyclosporin A solution.
    Midha R; Mackinnon SE; Evans PJ; Best TJ; Wong PY
    Microsurgery; 1992; 13(2):92-4. PubMed ID: 1569886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival.
    Jiang H; Sakuma S; Fujii Y; Akiyama Y; Ogawa T; Tamura K; Kobayashi M; Fujitsu T
    Transpl Int; 1999; 12(2):92-9. PubMed ID: 10363590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance.
    Piekoszewski W; Chow FS; Jusko WJ
    Drug Metab Dispos; 1993; 21(4):690-8. PubMed ID: 7690698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of cyclosporine pre- and post-liver transplantation.
    Hebert MF; Wacher VJ; Roberts JP; Benet LZ
    J Clin Pharmacol; 2003 Jan; 43(1):38-42. PubMed ID: 12520626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic interpretation of FK 506 levels in blood and in plasma during a European randomised study in primary liver transplant patients. The FK 506 European Study Group.
    Undre N; Möller A
    Transpl Int; 1994; 7 Suppl 1():S15-21. PubMed ID: 11271189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simvastatin-tacrolimus and simvastatin-cyclosporin interactions in rats.
    Yamada H; Kotaki H; Sawada Y; Iga T
    Biopharm Drug Dispos; 1998 Jul; 19(5):279-84. PubMed ID: 9673778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation.
    Naito T; Shinno K; Maeda T; Kagawa Y; Hashimoto H; Otsuka A; Takayama T; Ushiyama T; Suzuki K; Ozono S
    Biol Pharm Bull; 2006 Feb; 29(2):275-80. PubMed ID: 16462031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of clarithromycin on the bioavailability of cyclosporin in rats.
    Ohba M; Ohnishi N; Komada F; Iwakawa S; Okumura K
    Biol Pharm Bull; 1996 May; 19(5):733-7. PubMed ID: 8741585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in renal vascular resistance after intake of cyclosporin A and tacrolimus and reversal by nitroglycerin spray: a study in patients with stable renal allograft function.
    Weingart C; Leingärtner T; Bergler T; Krüger B; Böger C; Mack M; Banas B; Krämer BK
    Int J Clin Pharmacol Ther; 2006 Sep; 44(9):422-7. PubMed ID: 16995330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues.
    Tanaka C; Kawai R; Rowland M
    Drug Metab Dispos; 2000 May; 28(5):582-9. PubMed ID: 10772639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of streptozotocin-induced diabetes on cyclosporin A disposition in rats.
    Ogata M; Iizuka Y; Murata R; Hikichi N
    Biol Pharm Bull; 1996 Dec; 19(12):1586-90. PubMed ID: 8996644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
    Frey BM; Sieber M; Mettler D; Gänger H; Frey FJ
    Drug Metab Dispos; 1988; 16(2):285-9. PubMed ID: 2898348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomal formulations of cyclosporin A: influence of lipid type and dose on pharmacokinetics.
    Fahr A; Holz M; Fricker G
    Pharm Res; 1995 Aug; 12(8):1189-98. PubMed ID: 7494833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose dependent absorption and linear disposition of cyclosporin A in rat.
    Lindberg-Freijs A; Karlsson MO
    Biopharm Drug Dispos; 1994 Jan; 15(1):75-86. PubMed ID: 8161718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of baboon lymphocytes to cyclosporin A and FK 506: relative resistance of alloactivated cells to CyA.
    Stark JH; Smit JA; Gridelli B
    Transpl Int; 1994 Aug; 7(5):372-8. PubMed ID: 7527639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FK 506 versus cyclosporin in the prevention of renal allograft rejection--European pilot study: six-week results.
    Schleibner S; Krauss M; Wagner K; Erhard J; Christiaans M; van Hooff J; Buist L; Mayer D
    Transpl Int; 1995; 8(2):86-90. PubMed ID: 7539270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis.
    Al-Awwa IA; Hariharan S; First MR
    Am J Kidney Dis; 1998 Jun; 31(6 Suppl 1):S15-8. PubMed ID: 9631859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cyclosporine disposition in living related donor partial liver transplant recipients].
    Tada A; Tsuboughi S; Zenda H; Matsunami H; Ikegami T; Hashikura Y; Kitahara S; Terada M; Ishizone S; Kawasaki S
    Yakugaku Zasshi; 1993 Jan; 113(1):84-93. PubMed ID: 8463960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.